Machine learning, explained
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
A $7 per metric ton carbon tax could reduce emissions by the same amount as the flagship climate policies of the Obama administration, a new study finds.
By
Legatum Center event will focus on development, entrepreneurship and finance
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).